Ivan Stanojević
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
-
- Immune cells in cancer
- Galectins and Cancer Biology
Papers in
- Immunology 14
- Immune cells in cancer 4
- IL-33, ST2, and ILC Pathways 3
- Inflammation biomarkers and pathways 3
- Surgery 8
- Co-authors
- Danilo Vojvodić (40 shared papers)Maja Šurbatović (11 shared papers)Mirjana Djukić (15 shared papers)Nikola Stanković (7 shared papers)Džihan Abazović (11 shared papers)Dragan Djordjević (9 shared papers)Goran Rondović (9 shared papers)Snezana Milosavljevic (5 shared papers)
- Journals
- Food and Chemical Toxicology (2 papers)The Journal of Urology (1 paper)Chemico-Biological Interactions (1 paper)Inflammation Research (1 paper)International Immunology (1 paper)
- Partner nations
- SerbiaUnited KingdomMontenegro
In The Last Decade
Ivan Stanojević
50 papers receiving 682 citations
Peers
Comparison fields: 5 of 97
- Oncology 144
- Immunology 108
- Emergency Medicine 34
- Critical Care and Intensive Care Medicine 17
- Organic Chemistry 100
Countries citing papers authored by Ivan Stanojević
This map shows the geographic impact of Ivan Stanojević's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Stanojević with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Stanojević more than expected).
Fields of papers citing papers by Ivan Stanojević
This network shows the impact of papers produced by Ivan Stanojević. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Stanojević. The network helps show where Ivan Stanojević may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Stanojević, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 215 | |
| 2 | 2018 | 115 | |
| 3 | 2015 | 52 | |
| 4 | 2019 | 38 | |
| 5 | 2017 | 36 | |
| 6 | 2015 | 21 | |
| 7 | 2017 | 16 | |
| 8 | 2019 | 15 | |
| 9 | 2017 | 15 | |
| 10 | 2020 | 15 | |
| 11 | 2016 | 13 | |
| 12 | 2017 | 13 | |
| 13 | 2016 | 8 | |
| 14 | 2021 | 8 | |
| 15 | 2016 | 7 | |
| 16 | Association of locally produced IL10 and TGFb1 with tumor size, histological type and presence of metastases in patients with lung carcinoma. | 2017 | 7 |
| 17 | 2016 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2016 | 5 | |
| 20 | 2022 | 5 |
About Ivan Stanojević
Ivan Stanojević is a scholar working on Immunology, Surgery, Epidemiology, Oncology and Pulmonary and Respiratory Medicine, having authored 52 papers that have together received 689 indexed citations. Recurring topics across this work include Immune cells in cancer (4 papers), Sepsis Diagnosis and Treatment (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Intensive Care Unit Cognitive Disorders (3 papers), Heavy Metal Exposure and Toxicity (3 papers), Appendicitis Diagnosis and Management (3 papers), Inflammation biomarkers and pathways (3 papers) and Inflammatory Biomarkers in Disease Prognosis (3 papers). The work is most often cited by research in Oncology (144 citations), Immunology (108 citations), Emergency Medicine (34 citations), Critical Care and Intensive Care Medicine (17 citations) and Organic Chemistry (100 citations). Ivan Stanojević has collaborated with scholars based in Serbia, United Kingdom and Montenegro. Frequent co-authors include Danilo Vojvodić, Maja Šurbatović, Mirjana Djukić, Nikola Stanković, Džihan Abazović, Dragan Djordjević, Goran Rondović, Snezana Milosavljevic, Jasna Jevdjić and Ana Djurić. Their work appears in journals such as Food and Chemical Toxicology, The Journal of Urology, Chemico-Biological Interactions, Inflammation Research and International Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.